Saroja Pharma Industries India Ltd. - Research Center
Group () BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 23 | |
|---|---|
| Sales | 21.12 |
| Operating profit | 1.17 |
| Interest | 0.83 |
| Gross profit | 0.73 |
| EPS (Rs) | 1.25 |
Half yearly
results in details
| Sep ' 23 | |
|---|---|
| Other income | 0.39 |
| Stock adjustment | 3.60 |
| Raw material | 15.08 |
| Power and fuel | - |
| Employee expenses | 0.72 |
| Excise | - |
| Admin and selling expenses | - |
| Research and development expenses | - |
| Expenses capitalised | - |
| Other expenses | 0.54 |
| Provisions made | - |
| Depreciation | 0.04 |
| Taxation | 0.19 |
| Net profit / loss | 0.50 |
| Extra ordinary item | - |
| Prior year adjustments | - |
| Equity capital | 4.02 |
| Equity dividend rate | - |
| Agg.of non-prom. shares (Lacs) | - |
| Agg.of non promotoholding (%) | - |
| OPM (%) | 5.55 |
| GPM (%) | 3.40 |
| NPM (%) | 2.33 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis